Medicare GLP-1 Bridge Program Expands Access to Weight-Loss Treatment

Medicare GLP-1 Bridge Program expands access to weight-loss treatment

Some Medicare patients can now receive GLP-1 medication at a low cost.

COLUMN: Trial will offer Medicare recipients GLP-1 drugs without diagnosis

If you have eight friends, chances are good that at least one of them is currently taking a GLP-1 drug or has done so in the past. That’s because 12 percent or more of Americans report that they are taking or have taken the weight-loss medication. It was initially prescribed for weight loss, and insurance companies are covering the expensive weight-loss drug for people with diagnoses such as diabetes. However, Medicare insurance normally doesn’t…